Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders
ACS Pharmacology & Translational Science – February 10, 2025
Source: OpenAlex
Summary
Autism Spectrum Disorders affect millions globally, presenting significant challenges in social interaction. A compelling perspective in cognitive psychology explores how psychedelics like LSD, psilocybin, and MDMA may positively influence pro-social behaviors. This viewpoint examines their neurotransmitter receptor influence on behavior, suggesting novel drug studies. Understanding these mechanisms, alongside insights from nicotinic acetylcholine receptors, could offer new psychological approaches for individuals with ASD.
Abstract
Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions characterized by deficits in social interaction, communication, and repetitive behaviors. This viewpoint explores the potential mechanisms through which psychedelics such as lysergic acid diethylamide (LSD), psilocybin, and 3,4-methylenedioxymethamphetamine (MDMA) may positively influence pro-social behaviors, focusing on their implications for individuals with ASD.